Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Novan stock in Canada | $7.805
Own Novan shares in just a few minutes.
Novan is a biotechnology business based in the US. Novan stocks (NOVN.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $10.68 – a decrease of 6.53% over the previous week. Novan employs 23 staff and has a trailing 12-month revenue of around $4.5 million.
How to buy Novan stock in Canada
- Choose a platform. If you're a beginner, our stock trading table below can help you choose.
- Open your account. You'll need your ID, bank details and national insurance number.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: NOVN in this case.
- Research Novan stocks. The platform should provide the latest information available.
- Buy your Novan stocks. It's that simple.
What's in this guide?
- Can I buy shares in Novan?
- Has coronavirus impacted Novan shares?
- Novan shares summary
- Compare share dealing platforms
- Is Novan stock a buy or sell?
- Novan performance over time
- Can I short Novan shares?
- Novan's financials
- How volatile are Novan shares?
- Does Novan pay a dividend?
- Have Novan shares ever split?
- Other common questions
How has Coronavirus impacted Novan's stock price?
Since the stock market crash in March caused by coronavirus, Novan's stock price has had significant positive movement.
Its last market close was $7.805, which is 92.94% up on its pre-crash value of $0.5511 and 3,530.23% up on the lowest point reached during the March crash when the stocks fell as low as $0.215.
If you had bought $1,000 worth of Novan stocks at the start of February 2020, those stocks would have been worth $1,246.74 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $15,656.99.
Novan stock priceUse our graph to track the performance of NOVN stocks over time.
Novan stocks at a glance
|Latest market close||$7.805|
|52-week range||$3.67 - $25.9|
|50-day moving average||$10.0488|
|200-day moving average||$12.9313|
|Wall St. target price||$47|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.959|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Novan stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Novan price performance over time
|1 month (2021-06-25)||-26.92%|
|3 months (2021-04-26)||473.90%|
|Revenue TTM||USD$4.5 million|
|Gross profit TTM||USD$-3,907,000|
|Return on assets TTM||-41.53%|
|Return on equity TTM||0%|
|Market capitalisation||USD$168.7 million|
TTM: trailing 12 months
How to short and sell Novan stocks
- Create a CFD or spread betting account.
- Search for the stock code. E.g. "NOVN.US"
- Choose your position size.
- Select "sell" rather than "buy".
- Confirm your position and keep tabs on it. You may wish to set limits on your position.
There are currently 900,681 Novan stocks held short by investors – that's known as Novan's "short interest". This figure is 25.6% down from 1.2 million last month.
There are a few different ways that this level of interest in shorting Novan stocks can be evaluated.
Novan's "short interest ratio" (SIR)
Novan's "short interest ratio" (SIR) is the quantity of Novan stocks currently shorted divided by the average quantity of Novan stocks traded daily (recently around 10.0 million). Novan's SIR currently stands at 0.09. In other words for every 100,000 Novan stocks traded daily on the market, roughly 90 stocks are currently held short.
However Novan's short interest can also be evaluated against the total number of Novan stocks, or, against the total number of tradable Novan stocks (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Novan's short interest could be expressed as 0.05% of the outstanding stocks (for every 100,000 Novan stocks in existence, roughly 50 stocks are currently held short) or 0.0622% of the tradable stocks (for every 100,000 tradable Novan stocks, roughly 62 stocks are currently held short).
Such a low SIR usually points to an optimistic outlook for the stock price, with fewer people currently willing to bet against Novan.
Find out more about how you can short Novan stock.
Novan stock dividends
We're not expecting Novan to pay a dividend over the next 12 months. However, you can browse other dividend-paying stocks in our guide.
Have Novan stocks ever split?
Novan stocks were split on a 1:10 basis on 26 May 2021. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Novan stocks – just the quantity. However, indirectly, the new 900% higher stock price could have impacted the market appetite for Novan stocks which in turn could have impacted Novan's stock price.
Novan stock price volatility
Over the last 12 months, Novan's stocks have ranged in value from as little as $3.67 up to $25.9. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a stocks volatility in relation to the market. The market (NASDAQ average) beta is 1, while Novan's is -0.0349. This would suggest that Novan's stocks have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Novan has bucked the trend.
Novan, Inc., a clinical development-stage biotechnology company, provides nitric oxide-based therapies to treat dermatological and oncovirus-mediated diseases. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-spectrum anti-fungal gel for the treatment of fungal infections of the skin and nails, including athlete's foot and fungal nail infections; and SB414, a topical cream-based gel product candidate for the treatment of inflammatory skin diseases. The company also develops SB207, an anti-viral product candidate for the treatment of external genital warts; WH602, a nitric oxide-containing intravaginal gel to treat high-risk human papilloma virus (HPV); WH504, a non-gel formulation product candidate to treat high-risk HPV; and SB019 for the treatment of SARS-CoV-2. Novan, Inc. has a license agreement with Sato Pharmaceutical Co., Ltd.; and a strategic alliance with Orion Corporation. The company was incorporated in 2006 and is based in Durham, North Carolina.
Stocks similar to Novan
Novan in the news
Blue-chip earnings, travel stocks boost European shares
Blue-chip earnings, travel stocks boost European shares
European Stock Futures Mixed; SAP, Next Raise Forecasts Amid Earnings Rush By Investing.com
Frequently asked questions
More guides on Finder
How to buy Zevia PBC (ZVIA) stock in Canada
Everything we know about the Zevia PBC IPO, plus information on how to buy in.
How to buy Xponential Fitness (XPOF) stock in Canada
Everything we know about the Xponential Fitness IPO, plus information on how to buy in.
How to buy SOPHiA Genetics (SOPH) stock in Canada
Everything we know about the SOPHiA Genetics IPO, plus information on how to buy in.
How to buy Ryan Specialty Group Holdings (RYAN) stock in Canada
Everything we know about the Ryan Specialty Group Holdings IPO, plus information on how to buy in.
How to buy Ocean Biomedical (OCEA) stock in Canada when it goes public
Everything we know about the Ocean Biomedical IPO, plus information on how to buy in.
How to buy Instructure Holdings (INST) stock in Canada
Everything we know about the Instructure Holdings IPO, plus information on how to buy in.
How to buy Gambling.com Group (GAMB) stock in Canada
Everything we know about the Gambling.com Group IPO, plus information on how to buy in.
How to buy Elicio Therapeutics (ELTX) stock in Canada when it goes public
Everything we know about the Elicio Therapeutics IPO, plus information on how to buy in.
How to buy Cytek Biosciences (CTKB) stock in Canada
Everything we know about the Cytek Biosciences IPO, plus information on how to buy in.
How to buy Core & Main (CNM) stock in Canada
Everything we know about the Core & Main IPO, plus information on how to buy in.
Ask an Expert
You must be logged in to post a comment.